It's great to have more current data on managing phyllodes tumors. The historical 1cm margin requirement was excessive. This study found that only positive margins, not margin width, are related to recurrence. link.springer.com/article/10.124… #phyllodes #breasttumors

BRCA1, BRCA2, RAD51C, and RAD51D mutations were associated with exceptional benefit from rucaparib in ovarian cancer SGO IGCS ESGO OncoAlert ASCO ESMO - Eur. Oncology The Society of Gynecologic Oncology of Canada The GOG Foundation Inc. sciencedirect.com/science/articl…

#KELIM score may be a #marker of #chemosensitivity in patients with #ovarian #cancer treated with neoadjuvant chemotherapy 🇨🇦 Sabrina Piedimonte The Society of Gynecologic Oncology of Canada SGO IGCS ESGO ASCO ESMO - Eur. Oncology OncoAlert University Health Network sciencedirect.com/science/articl…

Now out in The Lancet Oncology and soon at #SABCS22 the results of the overall survival IA of MonarchE: at 4 years, abemaciclib is associated with⬆️IDFS (6.4%difference, HR 0.66, p<.0001). Further follow-up is needed to det if benefit in OS (HR 0.93;p=0·50). sciencedirect.com/science/articl…

Should we be using a new metric to counsel our patients with ovarian cancer on long-term survival? Ten-year conditional probability of survival for patients with ovarian... sciencedirect.com/science/articl… SGO IGCS Memorial Sloan Kettering Cancer Center

ENYGO prepared a special present for you. In this recent article we are covering the best orginal research presented for the first time during ESGO 2022 Congress in Berlin. Enjoy! buff.ly/3FCbRy6

ASCCP committee opinion on HPV vaccine when treatment ie with LEEP journals.lww.com/jlgtd/Fulltext…

In the January issue of BJS: Surgical knives: the scalpel academic.oup.com/bjs/article/11… Bas Wijnhoven Des Winter Kjetil Søreide Malin Sund Martyn Evans Niels Kok Paul Sutton Robert Hinchliffe Young BJS

Very proud to present our work investigating the value of HIPEC in the neoadjuvant setting (NHIPEC) among patients with ovarian cancer. BJOG! 😍amazing😊

The study found a dramatic reduction in medical errors resulting in harm or leading to patient death when first-year resident-physician work hours were limited hvrd.me/eqkv30sjH9O

#SLB in open #surgery for gynecological malignancies, via ⁦IJGC⁩ . I will record a video article like this using our developing eLight⁩…⁦Glauco Baiocchi⁩ ⁦Sociedade Brasileira de Cirurgia Oncológica (SBCO)⁩ ⁦EVA - Brazilian Gynecologic Oncology Group⁩ ⁦⁩ ⁦ISFGS⁩ ijgc.bmj.com/content/early/…

#ESTROnewsletter Partial breast irradiation versus whole Breast irradiation for early breast cancer patients in a randomised phase III trial: The Danish breast cancer group partial breast irradiation trial bit.ly/3hRXHBj

Surgical Management of the Axilla for Breast Cancer. pubmed.ncbi.nlm.nih.gov/36435614/

Honor to be the editor for this edition of @JWatch . Some fantastic pieces in here by Megan E. Tesch Ann Partridge MD, MPH Sibylle Loibl Dr. Michael Gnant Hope Rugo and others....all #bcsm! Sarah Cannon Docs OncoAlert

Reflecting on the remarkable impact of our @MDAndersonNews teams as highlighted in this article. Proud of our teammates’ collective efforts to advance our strategic Breakthroughs theme and our research mission for the benefit of our patients. bit.ly/3HOezDf #EndCancer

AJOG Systematic Review: Risk of endometrial cancer in asymptomatic postmenopausal women in relation to ultrasonographic endometrial thickness: systematic review and diagnostic test accuracy meta-analysis ow.ly/Icl750MfhMY

Routine SLN biopsy for endometrial intraepithelial neoplasia: A pragmatic approach or over-treatment? Emma Rossi Duke University School of Medicine Duke Ob/Gyn SGO IGCS ESGO OncoAlert sciencedirect.com/science/articl…

🇧🇷 Case report: Symptomatic uterine leiomyomatosis with intracaval and intracardiac invasion‼️SGO IGCS ESGO OncoAlert ACOG AHA Science The Society of Thoracic Surgeons sciencedirect.com/science/articl…

Basel_Refky I am sorry to hear that. Get well soon. You are putting GYN ONC in Egypt on the map.